Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aileen I Fernandez

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic TestAileen I Fernandez, Patricia Gaule, David L Rimm
JAMA Oncology|July 27, 2023
Classification of Breast Cancer According to ERBB2 Immunohistochemistry ScoresCharles J Robbins, Aileen I Fernandez, David L Rimm
Trends in Molecular Medicine|July 22, 2022
Evaluating diversity, equity, and inclusion consultation requestsAileen I Fernandez, Chrystal Starbird, Brionna Davis-Reyes, et al.
Trends in Cancer|June 7, 2022
Shadow mentoring: a cost-benefit review for reformBrionna Davis-Reyes, Chrystal Starbird, Aileen I Fernandez, et al.
Oncotarget|August 23, 2018
Homeoprotein DLX4 expression is increased in inflammatory breast cancer cases from an urban African-American populationJaehong Jeong, Tammey J Naab, Aileen I Fernandez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancerSaman Farahmand, Aileen I Fernandez, Fahad Shabbir Ahmed, et al.
JAMA Network Open|June 26, 2023
Domestic Violence Housing First Model and Association With Survivors' Housing Stability, Safety, and Well-being Over 2 YearsCris M Sullivan, Cortney Simmons, Mayra Guerrero, et al.
Breast Cancer Research : BCR|December 2, 2024
NF-κB associated markers of prognosis in early and metastatic triple negative breast cancerPayton De La Cruz, Julia McAdams, Melanie Morales Aquino, et al.
Oncotarget|December 2, 2017
Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine methodHenri Wathieu, Naiem T Issa, Aileen I Fernandez, et al.
Oncoimmunology|October 2, 2023
Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapySandra Martinez-Morilla, Myrto Moutafi, Aileen I Fernandez, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic TestAileen I Fernandez, Patricia Gaule, David L Rimm
JAMA Oncology|July 27, 2023
Classification of Breast Cancer According to ERBB2 Immunohistochemistry ScoresCharles J Robbins, Aileen I Fernandez, David L Rimm
Trends in Molecular Medicine|July 22, 2022
Evaluating diversity, equity, and inclusion consultation requestsAileen I Fernandez, Chrystal Starbird, Brionna Davis-Reyes, et al.
Trends in Cancer|June 7, 2022
Shadow mentoring: a cost-benefit review for reformBrionna Davis-Reyes, Chrystal Starbird, Aileen I Fernandez, et al.
Oncotarget|August 23, 2018
Homeoprotein DLX4 expression is increased in inflammatory breast cancer cases from an urban African-American populationJaehong Jeong, Tammey J Naab, Aileen I Fernandez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancerSaman Farahmand, Aileen I Fernandez, Fahad Shabbir Ahmed, et al.
JAMA Network Open|June 26, 2023
Domestic Violence Housing First Model and Association With Survivors' Housing Stability, Safety, and Well-being Over 2 YearsCris M Sullivan, Cortney Simmons, Mayra Guerrero, et al.
Breast Cancer Research : BCR|December 2, 2024
NF-κB associated markers of prognosis in early and metastatic triple negative breast cancerPayton De La Cruz, Julia McAdams, Melanie Morales Aquino, et al.
Oncotarget|December 2, 2017
Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine methodHenri Wathieu, Naiem T Issa, Aileen I Fernandez, et al.
Oncoimmunology|October 2, 2023
Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapySandra Martinez-Morilla, Myrto Moutafi, Aileen I Fernandez, et al.
Pageof 3